01

MAPK Signaling in Melanoma: From BRAF and NRAS to Combination Therapy

A Frontiers review maps BRAF- and NRAS-driven MAPK signaling in malignant melanoma and lays out the logic behind precision combination therapies for pathway-defined disease.